Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 129,290 | 163,488 | 205,530 | 236,284 | 256,146 |
| Marketable Securities | 98,875 | 99,042 | 99,696 | 5 | 10,031 |
| Receivables | 1,014 | 1,016 | 790 | 887 | 931 |
| TOTAL | $232,770 | $268,444 | $310,301 | $240,998 | $271,005 |
| Non-Current Assets | |||||
| PPE Net | 5,915 | 6,093 | 5,960 | 6,271 | 6,699 |
| Investments And Advances | 0 | 0 | 0 | 99,969 | 99,914 |
| Intangibles | 1,897 | 1,933 | 1,970 | 2,006 | 2,043 |
| Other Non-Current Assets | 19,504 | 20,355 | 21,180 | 21,989 | 22,779 |
| TOTAL | $27,316 | $28,381 | $29,110 | $130,235 | $131,435 |
| Total Assets | $260,086 | $296,825 | $339,411 | $371,233 | $402,440 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,920 | 1,721 | 2,818 | 1,516 | 1,755 |
| Accrued Expenses | 31,732 | 31,032 | 34,236 | 25,167 | 19,253 |
| TOTAL | $99,439 | $102,766 | $77,870 | $99,772 | $93,377 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 65,787 | 70,013 | 40,816 | 73,089 | 72,369 |
| Other Non-Current Liabilities | 16,076 | 17,077 | 18,056 | 19,017 | 19,921 |
| TOTAL | $111,939 | $125,865 | $262,000 | $159,787 | $178,110 |
| Total Liabilities | $211,378 | $228,631 | $339,870 | $259,559 | $271,487 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 65,950 | 65,398 | 65,393 | 65,249 | 65,157 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -581,793 | -557,609 | -623,562 | -507,496 | -484,912 |
| Other shareholders' equity | -1,162 | -919 | -242 | 52 | 15 |
| TOTAL | $48,708 | $68,194 | $-459 | $111,674 | $130,953 |
| Total Liabilities And Equity | $260,086 | $296,825 | $339,411 | $371,233 | $402,440 |